Quelles complications peuvent survenir avec le lymphome intraoculaire ?
Les complications incluent la perte de vision, le glaucome et des infections secondaires.
ComplicationsPerte de visionGlaucome
#2
Le lymphome intraoculaire peut-il entraîner des métastases ?
Oui, il peut se propager à d'autres parties du corps, bien que ce soit rare.
MétastasesPropagationRare
#3
Comment le traitement peut-il causer des complications ?
Les traitements comme la chimiothérapie peuvent affaiblir le système immunitaire, augmentant le risque d'infections.
ChimiothérapieSystème immunitaireInfections
#4
Le suivi régulier peut-il prévenir les complications ?
Oui, un suivi régulier permet de détecter et de traiter rapidement les complications.
Suivi régulierPréventionComplications
#5
Quelles sont les complications à long terme possibles ?
Les complications à long terme peuvent inclure des problèmes de vision persistants et des effets secondaires des traitements.
Complications à long termeProblèmes de visionEffets secondaires
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque du lymphome intraoculaire ?
Les principaux facteurs incluent l'immunodépression, l'âge avancé et certaines infections.
Facteurs de risqueImmunodépressionInfections
#2
Les antécédents familiaux augmentent-ils le risque ?
Oui, des antécédents familiaux de lymphome peuvent augmenter le risque de développer la maladie.
Antécédents familiauxRisqueLymphome
#3
Les personnes immunodéprimées sont-elles plus à risque ?
Oui, les personnes immunodéprimées, comme celles atteintes du VIH, ont un risque accru.
ImmunodépressionVIHRisque accru
#4
Certaines infections virales sont-elles des facteurs de risque ?
Oui, des infections comme le virus Epstein-Barr sont associées à un risque accru de lymphome.
Infections viralesVirus Epstein-BarrRisque accru
#5
L'exposition à des produits chimiques augmente-t-elle le risque ?
Certaines études suggèrent que l'exposition à des produits chimiques peut augmenter le risque de lymphome.
Produits chimiquesExpositionRisque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lymphome intraoculaire : Questions médicales les plus fréquentes",
"headline": "Lymphome intraoculaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lymphome intraoculaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-30",
"dateModified": "2025-04-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lymphome intraoculaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lymphomes",
"url": "https://questionsmedicales.fr/mesh/D008223",
"about": {
"@type": "MedicalCondition",
"name": "Lymphomes",
"code": {
"@type": "MedicalCode",
"code": "D008223",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.683.515.761"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Lymphome intraoculaire",
"alternateName": "Intraocular Lymphoma",
"code": {
"@type": "MedicalCode",
"code": "D064090",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Gezhi Xu",
"url": "https://questionsmedicales.fr/author/Gezhi%20Xu",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China."
}
},
{
"@type": "Person",
"name": "Satoru Kase",
"url": "https://questionsmedicales.fr/author/Satoru%20Kase",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan."
}
},
{
"@type": "Person",
"name": "Daiju Iwata",
"url": "https://questionsmedicales.fr/author/Daiju%20Iwata",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan."
}
},
{
"@type": "Person",
"name": "Kayo Suzuki",
"url": "https://questionsmedicales.fr/author/Kayo%20Suzuki",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan."
}
},
{
"@type": "Person",
"name": "Kenichi Namba",
"url": "https://questionsmedicales.fr/author/Kenichi%20Namba",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Comparative outcomes of extended distal pancreatectomy and distal pancreatectomy.",
"datePublished": "2022-12-25",
"url": "https://questionsmedicales.fr/article/36575100",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.asjsur.2022.12.044"
}
},
{
"@type": "ScholarlyArticle",
"name": "Post-pancreatectomy Acute Pancreatitis in Distal Pancreatectomies - a Rare Bird According to the New Definition.",
"datePublished": "2023-06-12",
"url": "https://questionsmedicales.fr/article/37308735",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11605-023-05721-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early experience with robotic central pancreatectomy with patient-reported outcomes and comparison with open central pancreatectomy.",
"datePublished": "2023-04-05",
"url": "https://questionsmedicales.fr/article/37021327",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jso.27266"
}
},
{
"@type": "ScholarlyArticle",
"name": "Glucose Regulation after Partial Pancreatectomy: A Comparison of Pancreaticoduodenectomy and Distal Pancreatectomy in the Short and Long Term.",
"datePublished": "2023-06-22",
"url": "https://questionsmedicales.fr/article/37349082",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4093/dmj.2022.0205"
}
},
{
"@type": "ScholarlyArticle",
"name": "Central pancreatectomy prevents postoperative diabetes.",
"datePublished": "2022-12-13",
"url": "https://questionsmedicales.fr/article/36457298",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jhbp.1296"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Syndromes immunoprolifératifs",
"item": "https://questionsmedicales.fr/mesh/D007160"
},
{
"@type": "ListItem",
"position": 4,
"name": "Syndromes lymphoprolifératifs",
"item": "https://questionsmedicales.fr/mesh/D008232"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lymphomes",
"item": "https://questionsmedicales.fr/mesh/D008223"
},
{
"@type": "ListItem",
"position": 6,
"name": "Lymphome intraoculaire",
"item": "https://questionsmedicales.fr/mesh/D064090"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lymphome intraoculaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lymphome intraoculaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-01",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lymphome intraoculaire",
"description": "Comment diagnostique-t-on un lymphome intraoculaire ?\nQuels tests sont utilisés pour confirmer le lymphome intraoculaire ?\nQuels signes cliniques indiquent un lymphome intraoculaire ?\nLe lymphome intraoculaire peut-il être confondu avec d'autres maladies ?\nQuel rôle joue la biopsie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Pancreatectomy#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lymphome intraoculaire",
"description": "Quels sont les symptômes courants du lymphome intraoculaire ?\nLe lymphome intraoculaire cause-t-il des changements de vision ?\nPeut-on avoir des symptômes sans douleur ?\nLes symptômes peuvent-ils varier d'un patient à l'autre ?\nY a-t-il des symptômes systémiques associés ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Pancreatectomy#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lymphome intraoculaire",
"description": "Peut-on prévenir le lymphome intraoculaire ?\nQuels facteurs de risque sont associés au lymphome intraoculaire ?\nLes infections peuvent-elles être évitées pour réduire le risque ?\nLe dépistage précoce aide-t-il à la prévention ?\nY a-t-il des recommandations pour les personnes à risque ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Pancreatectomy#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lymphome intraoculaire",
"description": "Quels traitements sont disponibles pour le lymphome intraoculaire ?\nLa chimiothérapie est-elle efficace pour ce type de lymphome ?\nLa radiothérapie est-elle utilisée dans le traitement ?\nQuand la chirurgie est-elle nécessaire ?\nY a-t-il des traitements expérimentaux disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Pancreatectomy#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lymphome intraoculaire",
"description": "Quelles complications peuvent survenir avec le lymphome intraoculaire ?\nLe lymphome intraoculaire peut-il entraîner des métastases ?\nComment le traitement peut-il causer des complications ?\nLe suivi régulier peut-il prévenir les complications ?\nQuelles sont les complications à long terme possibles ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Pancreatectomy#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lymphome intraoculaire",
"description": "Quels sont les principaux facteurs de risque du lymphome intraoculaire ?\nLes antécédents familiaux augmentent-ils le risque ?\nLes personnes immunodéprimées sont-elles plus à risque ?\nCertaines infections virales sont-elles des facteurs de risque ?\nL'exposition à des produits chimiques augmente-t-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=Pancreatectomy#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on un lymphome intraoculaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par examen ophtalmologique, imageries et biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le lymphome intraoculaire ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, l'IRM et l'analyse du liquide vitré."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un lymphome intraoculaire ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la vision floue, des douleurs oculaires et des lésions rétiniennes peuvent indiquer la maladie."
}
},
{
"@type": "Question",
"name": "Le lymphome intraoculaire peut-il être confondu avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec des infections ou d'autres tumeurs oculaires."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la biopsie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie permet d'analyser les cellules et de confirmer la présence de lymphome."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du lymphome intraoculaire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent vision floue, douleur, rougeur et décoloration de l'œil."
}
},
{
"@type": "Question",
"name": "Le lymphome intraoculaire cause-t-il des changements de vision ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner des changements de vision, y compris des taches ou des ombres."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans douleur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent avoir des symptômes sans douleur oculaire significative."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'un patient à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'étendue et de la localisation du lymphome."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques associés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes systémiques comme la fièvre et la perte de poids peuvent également survenir."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le lymphome intraoculaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés au lymphome intraoculaire ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, certaines infections virales et l'âge avancé."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être évitées pour réduire le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les infections virales comme le VIH peut réduire le risque de lymphome."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce aide-t-il à la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage précoce peut aider à identifier les problèmes oculaires avant qu'ils ne deviennent graves."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour les personnes à risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes à risque devraient consulter régulièrement un ophtalmologiste pour un suivi."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le lymphome intraoculaire ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chimiothérapie, la radiothérapie et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle efficace pour ce type de lymphome ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chimiothérapie est souvent efficace, surtout pour les lymphomes non hodgkiniens."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle utilisée dans le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut être utilisée pour cibler les cellules cancéreuses dans l'œil."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle nécessaire ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée si le lymphome provoque des complications ou ne répond pas aux autres traitements."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements expérimentaux comme les thérapies ciblées sont en cours d'évaluation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le lymphome intraoculaire ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de vision, le glaucome et des infections secondaires."
}
},
{
"@type": "Question",
"name": "Le lymphome intraoculaire peut-il entraîner des métastases ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut se propager à d'autres parties du corps, bien que ce soit rare."
}
},
{
"@type": "Question",
"name": "Comment le traitement peut-il causer des complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements comme la chimiothérapie peuvent affaiblir le système immunitaire, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Le suivi régulier peut-il prévenir les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier permet de détecter et de traiter rapidement les complications."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications à long terme possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications à long terme peuvent inclure des problèmes de vision persistants et des effets secondaires des traitements."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du lymphome intraoculaire ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'immunodépression, l'âge avancé et certaines infections."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux augmentent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de lymphome peuvent augmenter le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées, comme celles atteintes du VIH, ont un risque accru."
}
},
{
"@type": "Question",
"name": "Certaines infections virales sont-elles des facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections comme le virus Epstein-Barr sont associées à un risque accru de lymphome."
}
},
{
"@type": "Question",
"name": "L'exposition à des produits chimiques augmente-t-elle le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que l'exposition à des produits chimiques peut augmenter le risque de lymphome."
}
}
]
}
]
}
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China. Electronic address: qngchang@aliyun.com.
Department of Ophthalmology and Visual Science, Catholic University Lymphoma Group, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Patients with locally advanced pancreatic body/tail tumors, gastric cancer, or colon cancer often have contiguous organ involvement requiring extensive pancreatic resection. This study was performed t...
In total, 128 patients who underwent DP from January 2012 to January 2021 were retrospectively reviewed. Extended DP was defined according to the International Study Group of Pancreatic Surgery defini...
Of the 128 patients, 62 (48.4%) underwent extended DP and 66 (51.6%) underwent DP. Blood loss was greater (p < 0.001), the incidence of major complications was higher (p = 0.032), and the hospital sta...
Extended DP can be performed with comparable CR-POPF occurrence and mortality but increased morbidity when compared with standard DP....
Post-pancreatectomy acute pancreatitis (PPAP) is a recently identified clinical condition characterized by sustained elevated serum amylase levels for at least 48 h post-operatively, consistent radiol...
This retrospective single-center observational study included consecutive patients 18 years or older who underwent DP at Karolinska University Hospital between 2008 and 2020. The two serum amylase lev...
Of the 403 patients who underwent DP, 14% (n = 58) had sustained elevated serum amylase levels according to PPAP criteria, and 31% (n = 126) had transiently elevated serum amylase levels on either POD...
These findings indicate that PPAP after DP is rare and that computed tomography has limited usability for diagnosing PPAP. The findings also suggest that transiently elevated serum amylase may be an e...
Robotic central pancreatectomy (CP) has emerged in recent years as a noninferior approach to open CP and may offer improved patient-reported outcomes and reduction in incisional hernias....
All patients who underwent open and robotic CP between (2013 and 2022) were selected, and perioperative outcomes were analyzed. Patients who underwent robotic CP were interviewed over the phone to ass...
A total of 18 CP operations (56%-open vs. 44%-robotic) were identified. The overall median age was 67 years (interquartile range: 60-72), and 50% (n = 9) of patients were female. Median length of surg...
With the exception of longer operative times, robotic CP is a noninferior, definitive resection technique for select lesions of the middle pancreas. Additionally, the robotic approach may result in a ...
Long term quality of life is becoming increasingly crucial as survival following partial pancreatectomy rises. The purpose of this study was to investigate the difference in glucose dysregulation afte...
In this prospective observational study from 2015 to 2018, 224 patients who underwent partial pancreatectomy were selected: 152 (67.9%) received PD and 72 (32.1%) received DP. Comprehensive assessment...
The disposition index, an integrated measure of β-cell function, decreased 1 week after surgery in both groups, but it increased more than baseline level in the PD group while its decreased level was ...
Proactive surveillance of glucose dysregulation is advised, particularly for patients who receive DP....
Central pancreatectomy (CP) can be performed as an alternative surgical approach to distal pancreatectomy (DP) in the treatment of benign or low-grade malignant lesions located in the neck and body of...
Patients who received CP in a large tertiary care pancreatic surgery center between 2001 and 2020 were identified from a prospectively maintained database and compared via propensity score matching wi...
One hundred and seven patients undergoing open CP were compared to 107 patients with open DP. No significant difference in rates or severity of most surgical complications could be found including pos...
CP offers an improved endocrine long-term outcome at the expense of a higher risk of PPH without increased perioperative mortality. As evidence on this parenchyma sparing surgical technique is sparse,...
The incidence of clinically relevant postoperative pancreatic fistula (CR-POPF) after central pancreatectomy (CP) is high, yet an effective predictive method is currently lacking. This study aimed to ...
A retrospective analysis was conducted on patients undergoing CP at our institution between January 2010 and July 2022. The primary outcome was CR-POPF (grade B/C) according to the 2016 International ...
A total of 115 patients undergoing CP were included. Among them, 38 (33%) were male, with a median age of 53 years. CR-POPF occurred in 35 (30.4%) patients, specifically 33 (28.7%) with grade B and 2 ...
The derived C-FRS models show potential for accurately predicting the development of CR-POPF after CP. However, further validation studies are required to determine the most effective model. In the me...
Total pancreatectomy with islet autotransplantation is a therapeutic option to effectively achieve pain relief and improvements in quality of life for selected patients with debilitating pain from chr...
Laparoscopic distal pancreatectomy (LDP) and laparoscopic central pancreatectomy (LCP) are two surgical methods that can remove pancreatic neck lesions. However, their benefits remain controversial. W...
In total, 50 patients who underwent LDP (n = 34) or LCP (n =16) between January 2014 and November 2019 were retrospectively reviewed using our database. We analyzed their preoperative characteristics,...
The baseline features of patients did not differ significantly between the two groups (P < 0.05). Compared with the LDP group, the LCP group showed significantly prolonged operation time (392 ± 144 vs...
Compared with the LCP, LDP is a useful and safer technique for benign or low-grade malignant tumors in the pancreatic neck....
Minimally invasive (MI) surgery has been widely adopted to treat left-sided pancreatic cancer. However, outcomes are not clearly defined....
Retrospective cohort study utilizing NCDB and NSQIP data....
Patients undergoing distal pancreatectomy for pancreatic adenocarcinoma from 2004 to 2016 were included (n = 7347). Utilizing NSQIP (n = 2406), patients were divided into two groups: intention-to-trea...
Based on these data, MI distal pancreatectomy could be considered a standard of care for pancreatic cancer when technically feasible. Although morbidity and mortality were similar, the laparoscopic ap...
Distal pancreatectomy (DP) is currently well established as a minimally invasive surgery (MIS) procedure, using either a laparoscopic (LDP) or robotic (RDP) approach....
Out of 83 DP performed between January 2018 and March 2022, 57 cases (68.7%) were performed using MIS: 35 LDP and 22 RDP (da Vinci Xi). We have assessed the experience with the two techniques and anal...
The mean operative times for LDP and RDP were 201.2 (SD 47.8) and 247.54 (SD 35.8) minutes, respectively (P = NS). No differences were observed in length of hospital stay or conversion rate: 6 (5-34) ...
Minimally invasive distal pancreatectomy (MIDP) is a safe and feasible procedure in selected patients. Surgical planning and stepwise implementation based on prior experience help surgeons successfull...
